Status:
COMPLETED
Sex-related Differences in the Response to the Muscle Relaxant Drug Mivacurium
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
Oslo University Hospital
Conditions:
Muscle Relaxation
Sex
Eligibility:
All Genders
18-45 years
Phase:
PHASE1
Brief Summary
Muscle relaxants are drugs providing muscle relaxation during surgical treatment. Previous studies have shown that males and females respond differently to this kind of drug. Our hypothesis is that ma...
Detailed Description
Muscle relaxants are a type of drug used to provide muscle relaxation during induction of anesthesia and surgical treatment. Residual drug effect postoperatively (i.e. residual muscle relaxation) occu...
Eligibility Criteria
Inclusion
- Healthy individuals with no current medication -
Exclusion
- Previous complications during anesthesia, pregnancy, allergy to muscle relaxants, smoking, gastrointestinal reflux.
- \-
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01906528
Start Date
March 1 2013
End Date
July 1 2013
Last Update
April 11 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, UCSF
San Francisco, California, United States, 94131